MTA1

This article is about proteins. For the Islamic TV channel, see MTA1 World.

MTA1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesMTA1, metastasis associated 1
External IDsOMIM: 603526; MGI: 2150037; HomoloGene: 3442; GeneCards: MTA1; OMA:MTA1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

9112

116870

Ensembl

ENSG00000182979

ENSMUSG00000021144

UniProt

Q13330

Q8K4B0

RefSeq (mRNA)

NM_001203258
NM_004689

RefSeq (protein)

NP_001190187
NP_004680

Location (UCSC)Chr 14: 105.42 – 105.47 MbChr 12: 113.06 – 113.1 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Metastasis-associated protein MTA1 is a protein that in humans is encoded by the MTA1 gene. MTA1 is the founding member of the MTA family of genes.[5][6] MTA1 is primarily localized in the nucleus but also found to be distributed in the extra-nuclear compartments.[7] MTA1 is a component of several chromatin remodeling complexes including the nucleosome remodeling and deacetylation complex (NuRD).[8][9] MTA1 regulates gene expression by functioning as a coregulator to integrate DNA-interacting factors to gene activity.[10] MTA1 participates in physiological functions in the normal and cancer cells.[11][12] MTA1 is one of the most upregulated proteins in human cancer and associates with cancer progression, aggressive phenotypes, and poor prognosis of cancer patients.[9][13]

Discovery

[edit]

MTA1 was first cloned by Toh, Pencil and Nicholson in 1994 as a differentially expressed gene in a highly metastatic rat breast cancer cell line.[5][6] The role in MTA1 in chromatin remodeling was deduced due to the presence of MTA1 polypeptides in the NuRD complex.[8] The first direct target of the MTA1-NuRD complex was ERα.[14] MTA2 was initially recognized as MTA1-like 1 gene, named as MTA1-L1, as a randomly selected clone from a large-scale sequencing effort of human cDNAs by Takashi Tokino's laboratory. MTA2's suspected role in chromatin remodeling was inferred from the prevalence of MTA2 polypeptides with the NuRD complex in a proteomic study.[15][16]

Gene and spliced variants

[edit]

The MTA1 is 715/703 amino acids long, coded by one of three genes of the MTA family and localized on chromosome 14q32 in human and on chromosome 12F in mouse. There are 21 exons spread over a region of about 51-kb in human MTA1. Alternative splicing from 21 exons generates 20 transcripts, ranging from 416-bp to 2.9-kb long.[16] However, open-reading frames are present only in eight spliced transcripts which code six proteins and two polypeptides and remaining transcripts are non-coding long RNAs some of which retain intron sequences. Murine Mta1 contains three protein coding transcripts and three non-coding RNA transcripts.[16] Among human MTA1 variants, only two spliced variants are characterized: ZG29p variant is derived from the c-terminal MTA1, with 251 amino acids and 29-kDa molecular weight;[17] and MTA1s variant generated from alternative splicing of a middle exon followed by a frame-shift, is 430 amino acids and 47-kDa molecular weight.[18]

Protein domains

[edit]

The conserved domains of MTA1 include a BAH (Bromo-Adjacent Homology), an ELM2 (egl-27 and MTA1 homology), a SANT (SWI, ADA2, N-CoR, TFIIIB-B) and a GATA-like zinc finger. The C-terminal divergent region of MTA1 has an Src homology 3-binding domain, acidic regions, and nuclear localization signals. The presence of these domains revealed the role of MTA1 in interactions with modified or unmodified histone and non-histone proteins, chromatin remodeling, and modulation of gene transcription.[9][19][20][21] MTA1 undergoes multiple post-translation modifications: acetylation on lysine 626, ubiquitination on lysine 182 and lysine 626, sumoylation on lysine 509, and methylation on lysine 532.[22][23][24] The structural insights of MTA1 domains are deduced from studies involving complexes with HDAC1 or RbAp48 subunits of the NuRD complexes.[19][20] The MTA1s variant is an N-terminal portion of MTA1 without nuclear localization sequence but contains a novel sequence of 33 amino acids in its C-terminal region. The novel sequence harbors a nuclear receptor binding motif LXXLL which confers MTA1 with an ability to interact with estrogen receptor alpha or other type I nuclear receptors.[18] The ZG29p variant represents the c-terminal MTA1 with two proline-rich SH3 binding sites.[17][25]

Regulation

[edit]

Expression of MTA1 is influenced by transcription and non-transcriptional mechanisms. MTA1 expression is regulated by growth factors, growth factor receptors, oncogenes, environmental stress, ionizing radiation, inflammation, and hypoxia.[9][12] The transcription of MTA1 is stimulated by transcriptional factors including, c-Myc,[26] SP1,[27] CUTL1 homeodomain,[28] NF-ḵB,[29] HSF1,[30] HIF-1a,[31] and Clock/BMAL1 complex,[32] and inhibited by p53.[33] Non-genomic mechanisms of MTA1 expression include post-transcriptional regulations such as ubiquitination by RING-finger ubiquitin-protein ligase COP1 [34] or interaction with tumor suppressor ARF [24] or micro-RNAs such as miR-30c, miR-661 and miR-125a-3p.[35][36][37][38]

Targets

[edit]

Functions of MTA1 are regulated by its post-translational modifications, modulating the roles of effector molecules, interacting with other regulatory proteins and chromatin remodeling machinery, and modulating the expression of target genes via interacting with the components of the NuRD complex including HDACs.[9][19][20]

MTA1 suppresses transcription of breast cancer type 1 susceptibility gene,[39] PTEN,[40] p21WAF,[41] guanine nucleotide-binding protein G(i) subunit alpha-2,[22] SMAD family member 7,[42] nuclear receptor subfamily 4 group A member 1,[43] and homeobox protein SIX3,[44] and represses BCL11B[45] as well as E-cadherin expression.[46][47]

MTA1 is a dual coregulatory as it stimulates the transcription of Stat3,[48] breast cancer-amplified sequence 3,[49] FosB,[28] paired box gene 5,[50] transglutaminase 2,[51] myeloid differentiation primary response 88,[52] tumor suppressorp14/p19ARF,[27][53] tyrosine hydroxylase,[54] clock gene CRY1,[32] SUMO2,[23] and Wnt1 and rhodopsin due to release of their transcriptional inhibition by homeodomain protein Six3,[44][55]

MTA1 interacts with ERα and coregulatory factors such as MAT1,[56] MICoA,[57][58] and LMO4,[59] which inhibits ER transactivation activity.[14] MTA1 also deacetylate its target proteins such as p53 and HIF and modulates their transactivation functions.[60][61] Furthermore, MTA1 could potentially modulate the expression of target genes through the microRNA network as MTA1 knockdown results modulation of miR-210, miR-125b, miR-194, miR-103, and miR-500.[62][63]

Cellular functions

[edit]

MTA1 modulates the expression of target genes due to its ability to act as a corepressor or coactivator. MTA1 targets and/or effector pathways regulate pathways with cellular functions in both normal and cancer cells.[11][12] Physiological functions of MTA1 include: its role in the brain due to MTA1 interactions with DJ1[53] and endophilin-3;[64] regulation of rhodopsin expression in the mouse eye; modifier of circadian rhythm due to MTA1 interactions with the CLOCK-BMAL1 complex and stimulation of Cry-transcription; in heart development due to MTA1-FOG2 interaction; in mammary gland development as MTA1 depletion leads to ductal hypobranching, in spermatogenesis; in immunomodulation due to differential effects on the expression of cytokines in the resting and activated macrophage; in liver regeneration following hepatic injury; differentiation of mesenchymal stem cells into osteogenic axis; and a component of DNA-damage response.[11] In cancer cells, MTA1 and its downstream effectors regulate genes and/or pathways with roles in transformation, invasion, survival, angiogenesis, epithelial-to-mesenchymal transition, metastasis, DNA damage response, and hormone-independence of breast cancer.[9][12]

Notes

[edit]

References

[edit]
  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000182979 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000021144 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b Toh Y, Pencil SD, Nicolson GL (September 1994). "A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses". The Journal of Biological Chemistry. 269 (37): 22958–22963. doi:10.1016/S0021-9258(17)31603-4. PMID 8083195.
  6. ^ a b Toh Y, Nicolson GL (December 2014). "Properties and clinical relevance of MTA1 protein in human cancer". Cancer and Metastasis Reviews. 33 (4): 891–900. doi:10.1007/s10555-014-9516-2. PMID 25359582. S2CID 17852701.
  7. ^ Liu J, Wang H, Huang C, Qian H (December 2014). "Subcellular localization of MTA proteins in normal and cancer cells". Cancer and Metastasis Reviews. 33 (4): 843–856. doi:10.1007/s10555-014-9511-7. PMID 25398252. S2CID 7959609.
  8. ^ a b Xue Y, Wong J, Moreno GT, Young MK, Côté J, Wang W (December 1998). "NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities". Molecular Cell. 2 (6): 851–861. doi:10.1016/s1097-2765(00)80299-3. PMID 9885572.
  9. ^ a b c d e f Li DQ, Kumar R (2015). "Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer". Advances in Cancer Research. Vol. 127. pp. 1–47. doi:10.1016/bs.acr.2015.04.005. ISBN 9780128029206. PMID 26093897.
  10. ^ Kumar R, Gururaj AE (2008). "Coregulators as Oncogenes and Tumor Suppressors". In O'Malley BW, Kumar R (eds.). Nuclear Receptor Coregulators and Human Diseases. Hackensack, N.J.: World Scientific. pp. 195–218. doi:10.1142/9789812819178_0004. ISBN 978-981-281-917-8.
  11. ^ a b c Sen N, Gui B, Kumar R (December 2014). "Physiological functions of MTA family of proteins". Cancer and Metastasis Reviews. 33 (4): 869–877. doi:10.1007/s10555-014-9514-4. PMC 4245464. PMID 25344801.
  12. ^ a b c d Sen N, Gui B, Kumar R (December 2014). "Role of MTA1 in cancer progression and metastasis". Cancer and Metastasis Reviews. 33 (4): 879–889. doi:10.1007/s10555-014-9515-3. PMC 4245458. PMID 25344802.
  13. ^ Kumar R (December 2014). "Functions and clinical relevance of MTA proteins in human cancer. Preface". Cancer and Metastasis Reviews. 33 (4): 835. doi:10.1007/s10555-014-9509-1. PMC 4245326. PMID 25348751.
  14. ^ a b Mazumdar A, Wang RA, Mishra SK, Adam L, Bagheri-Yarmand R, Mandal M, et al. (January 2001). "Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor". Nature Cell Biology. 3 (1): 30–37. doi:10.1038/35050532. PMID 11146623. S2CID 23477845.
  15. ^ Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D (August 1999). "Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation". Genes & Development. 13 (15): 1924–35. doi:10.1101/gad.13.15.1924. PMC 316920. PMID 10444591.
  16. ^ a b c Kumar R, Wang RA (May 2016). "Structure, expression and functions of MTA genes". Gene. 582 (2): 112–121. doi:10.1016/j.gene.2016.02.012. PMC 4785049. PMID 26869315.
  17. ^ a b Kleene R, Zdzieblo J, Wege K, Kern HF (August 1999). "A novel zymogen granule protein (ZG29p) and the nuclear protein MTA1p are differentially expressed by alternative transcription initiation in pancreatic acinar cells of the rat". Journal of Cell Science. 112 (15): 2539–2548. doi:10.1242/jcs.112.15.2539. PMID 10393810.
  18. ^ a b Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang Z, et al. (August 2002). "A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm". Nature. 418 (6898): 654–657. Bibcode:2002Natur.418..654K. doi:10.1038/nature00889. PMID 12167865. S2CID 4355677.
  19. ^ a b c Millard CJ, Watson PJ, Celardo I, Gordiyenko Y, Cowley SM, Robinson CV, et al. (July 2013). "Class I HDACs share a common mechanism of regulation by inositol phosphates". Molecular Cell. 51 (1): 57–67. doi:10.1016/j.molcel.2013.05.020. PMC 3710971. PMID 23791785.
  20. ^ a b c Alqarni SS, Murthy A, Zhang W, Przewloka MR, Silva AP, Watson AA, et al. (August 2014). "Insight into the architecture of the NuRD complex: structure of the RbAp48-MTA1 subcomplex". The Journal of Biological Chemistry. 289 (32): 21844–21855. doi:10.1074/jbc.M114.558940. PMC 4139204. PMID 24920672.
  21. ^ Millard CJ, Fairall L, Schwabe JW (December 2014). "Towards an understanding of the structure and function of MTA1". Cancer and Metastasis Reviews. 33 (4): 857–867. doi:10.1007/s10555-014-9513-5. PMC 4244562. PMID 25352341.
  22. ^ a b Ohshiro K, Rayala SK, Wigerup C, Pakala SB, Natha RS, Gururaj AE, et al. (September 2010). "Acetylation-dependent oncogenic activity of metastasis-associated protein 1 co-regulator". EMBO Reports. 11 (9): 691–697. doi:10.1038/embor.2010.99. PMC 2933879. PMID 20651739.
  23. ^ a b Cong L, Pakala SB, Ohshiro K, Li DQ, Kumar R (December 2011). "SUMOylation and SUMO-interacting motif (SIM) of metastasis tumor antigen 1 (MTA1) synergistically regulate its transcriptional repressor function". The Journal of Biological Chemistry. 286 (51): 43793–43808. doi:10.1074/jbc.M111.267237. PMC 3243521. PMID 21965678.
  24. ^ Nair SS, Li DQ, Kumar R (February 2013). "A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes". Molecular Cell. 49 (4): 704–718. doi:10.1016/j.molcel.2012.12.016. PMC 3582764. PMID 23352453.
  25. ^ Kleene R, Classen B, Zdzieblo J, Schrader M (August 2000). "SH3 binding sites of ZG29p mediate an interaction with amylase and are involved in condensation-sorting in the exocrine rat pancreas". Biochemistry. 39 (32): 9893–9900. doi:10.1021/bi000876i. PMID 10933808.
  26. ^ Zhang XY, DeSalle LM, Patel JH, Capobianco AJ, Yu D, Thomas-Tikhonenko A, et al. (September 2005). "Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein". Proceedings of the National Academy of Sciences of the United States of America. 102 (39): 13968–13973. Bibcode:2005PNAS..10213968Z. doi:10.1073/pnas.0502330102. PMC 1236531. PMID 16172399.
  27. ^ a b Li DQ, Pakala SB, Reddy SD, Ohshiro K, Zhang JX, Wang L, et al. (May 2011). "Bidirectional autoregulatory mechanism of metastasis-associated protein 1-alternative reading frame pathway in oncogenesis". Proceedings of the National Academy of Sciences of the United States of America. 108 (21): 8791–8796. Bibcode:2011PNAS..108.8791L. doi:10.1073/pnas.1018389108. PMC 3102345. PMID 21555589.
  28. ^ a b Pakala SB, Singh K, Reddy SD, Ohshiro K, Li DQ, Mishra L, et al. (May 2011). "TGF-β1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells". Oncogene. 30 (19): 2230–2241. doi:10.1038/onc.2010.608. PMC 3617575. PMID 21258411.
  29. ^ Li DQ, Pakala SB, Nair SS, Eswaran J, Kumar R (January 2012). "Metastasis-associated protein 1/nucleosome remodeling and histone deacetylase complex in cancer". Cancer Research. 72 (2): 387–394. doi:10.1158/0008-5472.CAN-11-2345. PMC 3261506. PMID 22253283.
  30. ^ Khaleque MA, Bharti A, Gong J, Gray PJ, Sachdev V, Ciocca DR, et al. (March 2008). "Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1". Oncogene. 27 (13): 1886–1893. doi:10.1038/sj.onc.1210834. hdl:11336/80376. PMID 17922035. S2CID 7056025.
  31. ^ Yoo YG, Kong G, Lee MO (March 2006). "Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1". The EMBO Journal. 25 (6): 1231–1241. doi:10.1038/sj.emboj.7601025. PMC 1422150. PMID 16511565.
  32. ^ a b Li DQ, Pakala SB, Reddy SD, Peng S, Balasenthil S, Deng CX, et al. (2013). "Metastasis-associated protein 1 is an integral component of the circadian molecular machinery". Nature Communications. 4: 2545. Bibcode:2013NatCo...4.2545L. doi:10.1038/ncomms3545. PMID 24089055.
  33. ^ Li DQ, Divijendra Natha Reddy S, Pakala SB, Wu X, Zhang Y, Rayala SK, et al. (December 2009). "MTA1 coregulator regulates p53 stability and function". The Journal of Biological Chemistry. 284 (50): 34545–34552. doi:10.1074/jbc.M109.056499. PMC 2787316. PMID 19837670.
  34. ^ Li DQ, Ohshiro K, Reddy SD, Pakala SB, Lee MH, Zhang Y, et al. (October 2009). "E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1". Proceedings of the National Academy of Sciences of the United States of America. 106 (41): 17493–17498. Bibcode:2009PNAS..10617493L. doi:10.1073/pnas.0908027106. PMC 2762678. PMID 19805145.
  35. ^ Zhang Y, Wang XF (December 2014). "Post-transcriptional regulation of MTA family by microRNAs in the context of cancer". Cancer and Metastasis Reviews. 33 (4): 1011–1016. doi:10.1007/s10555-014-9526-0. PMC 4245459. PMID 25332146.
  36. ^ Kong X, Xu X, Yan Y, Guo F, Li J, Hu Y, et al. (2014). "Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer". PLOS ONE. 9 (3): e90810. Bibcode:2014PLoSO...990810K. doi:10.1371/journal.pone.0090810. PMC 3940948. PMID 24595016.
  37. ^ Reddy SD, Pakala SB, Ohshiro K, Rayala SK, Kumar R (July 2009). "MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions". Cancer Research. 69 (14): 5639–5642. doi:10.1158/0008-5472.CAN-09-0898. PMC 2721803. PMID 19584269.
  38. ^ Zhang H, Zhu X, Li N, Li D, Sha Z, Zheng X, et al. (July 2015). "miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion". Acta Biochimica et Biophysica Sinica. 47 (7): 496–503. doi:10.1093/abbs/gmv039. PMID 25998575.
  39. ^ Molli PR, Singh RR, Lee SW, Kumar R (March 2008). "MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene". Oncogene. 27 (14): 1971–1980. doi:10.1038/sj.onc.1210839. PMC 2705285. PMID 17922032.
  40. ^ Reddy SD, Pakala SB, Molli PR, Sahni N, Karanam NK, Mudvari P, et al. (August 2012). "Metastasis-associated protein 1/histone deacetylase 4-nucleosome remodeling and deacetylase complex regulates phosphatase and tensin homolog gene expression and function". The Journal of Biological Chemistry. 287 (33): 27843–27850. doi:10.1074/jbc.M112.348474. PMC 3431680. PMID 22700976.
  41. ^ Li DQ, Pakala SB, Reddy SD, Ohshiro K, Peng SH, Lian Y, et al. (March 2010). "Revelation of p53-independent function of MTA1 in DNA damage response via modulation of the p21 WAF1-proliferating cell nuclear antigen pathway". The Journal of Biological Chemistry. 285 (13): 10044–10052. doi:10.1074/jbc.M109.079095. PMC 2843167. PMID 20071335.
  42. ^ Salot S, Gude R (January 2013). "MTA1-mediated transcriptional repression of SMAD7 in breast cancer cell lines". European Journal of Cancer. 49 (2): 492–499. doi:10.1016/j.ejca.2012.06.019. PMID 22841502.
  43. ^ Yu L, Su YS, Zhao J, Wang H, Li W (August 2013). "Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells". FEBS Letters. 587 (16): 2542–2551. doi:10.1016/j.febslet.2013.06.029. PMID 23831020. S2CID 6726902.
  44. ^ a b Kumar R, Balasenthil S, Manavathi B, Rayala SK, Pakala SB (August 2010). "Metastasis-associated protein 1 and its short form variant stimulates Wnt1 transcription through promoting its derepression from Six3 corepressor". Cancer Research. 70 (16): 6649–6658. doi:10.1158/0008-5472.CAN-10-0909. PMC 3711655. PMID 20682799.
  45. ^ Cismasiu VB, Adamo K, Gecewicz J, Duque J, Lin Q, Avram D (October 2005). "BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter". Oncogene. 24 (45): 6753–6764. doi:10.1038/sj.onc.1208904. PMID 16091750.
  46. ^ Weng W, Yin J, Zhang Y, Qiu J, Wang X (March 2014). "Metastasis-associated protein 1 promotes tumor invasion by downregulation of E-cadherin". International Journal of Oncology. 44 (3): 812–818. doi:10.3892/ijo.2014.2253. PMID 24424621.
  47. ^ Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, Brüning A (September 2008). "The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO". Cancer Biology & Therapy. 7 (9): 1460–1467. doi:10.4161/cbt.7.9.6427. PMID 18719363.
  48. ^ Pakala SB, Rayala SK, Wang RA, Ohshiro K, Mudvari P, Reddy SD, et al. (June 2013). "MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer". Cancer Research. 73 (12): 3761–3770. doi:10.1158/0008-5472.CAN-12-3998. PMC 3686857. PMID 23580571.
  49. ^ Gururaj AE, Singh RR, Rayala SK, Holm C, den Hollander P, Zhang H, et al. (April 2006). "MTA1, a transcriptional activator of breast cancer amplified sequence 3". Proceedings of the National Academy of Sciences of the United States of America. 103 (17): 6670–6675. Bibcode:2006PNAS..103.6670G. doi:10.1073/pnas.0601989103. PMC 1458939. PMID 16617102.
  50. ^ Balasenthil S, Gururaj AE, Talukder AH, Bagheri-Yarmand R, Arrington T, Haas BJ, et al. (August 2007). "Identification of Pax5 as a target of MTA1 in B-cell lymphomas". Cancer Research. 67 (15): 7132–7138. doi:10.1158/0008-5472.CAN-07-0750. PMID 17671180.
  51. ^ Ghanta KS, Pakala SB, Reddy SD, Li DQ, Nair SS, Kumar R (March 2011). "MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response". The Journal of Biological Chemistry. 286 (9): 7132–7138. doi:10.1074/jbc.M110.199273. PMC 3044970. PMID 21156794.
  52. ^ Pakala SB, Reddy SD, Bui-Nguyen TM, Rangparia SS, Bommana A, Kumar R (October 2010). "MTA1 coregulator regulates LPS response via MyD88-dependent signaling". The Journal of Biological Chemistry. 285 (43): 32787–32792. doi:10.1074/jbc.M110.151340. PMC 2963354. PMID 20702415.
  53. ^ a b Li DQ, Kumar R (June 2010). "Mi-2/NuRD complex making inroads into DNA-damage response pathway". Cell Cycle. 9 (11): 2071–2079. doi:10.4161/cc.9.11.11735. PMC 3631012. PMID 20505336.
  54. ^ Reddy SD, Rayala SK, Ohshiro K, Pakala SB, Kobori N, Dash P, et al. (March 2011). "Multiple coregulatory control of tyrosine hydroxylase gene transcription". Proceedings of the National Academy of Sciences of the United States of America. 108 (10): 4200–4205. Bibcode:2011PNAS..108.4200R. doi:10.1073/pnas.1101193108. PMC 3054001. PMID 21368136.
  55. ^ Manavathi B, Peng S, Rayala SK, Talukder AH, Wang MH, Wang RA, et al. (August 2007). "Repression of Six3 by a corepressor regulates rhodopsin expression". Proceedings of the National Academy of Sciences of the United States of America. 104 (32): 13128–13133. Bibcode:2007PNAS..10413128M. doi:10.1073/pnas.0705878104. PMC 1941821. PMID 17666527.
  56. ^ Talukder AH, Mishra SK, Mandal M, Balasenthil S, Mehta S, Sahin AA, et al. (March 2003). "MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions". The Journal of Biological Chemistry. 278 (13): 11676–11685. doi:10.1074/jbc.M209570200. PMID 12527756.
  57. ^ Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, Yu W, et al. (May 2003). "MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions". The Journal of Biological Chemistry. 278 (21): 19209–19219. doi:10.1074/jbc.M301968200. PMID 12639951.
  58. ^ Talukder AH, Gururaj A, Mishra SK, Vadlamudi RK, Kumar R (August 2004). "Metastasis-associated protein 1 interacts with NRIF3, an estrogen-inducible nuclear receptor coregulator". Molecular and Cellular Biology. 24 (15): 6581–6591. doi:10.1128/MCB.24.15.6581-6591.2004. PMC 444867. PMID 15254226.
  59. ^ Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R (November 2005). "Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein". Cancer Research. 65 (22): 10594–10601. doi:10.1158/0008-5472.CAN-05-2268. PMID 16288053.
  60. ^ Moon HE, Cheon H, Lee MS (November 2007). "Metastasis-associated protein 1 inhibits p53-induced apoptosis". Oncology Reports. 18 (5): 1311–1314. doi:10.3892/or.18.5.1311. PMID 17914590.
  61. ^ Moon HE, Cheon H, Chun KH, Lee SK, Kim YS, Jung BK, et al. (October 2006). "Metastasis-associated protein 1 enhances angiogenesis by stabilization of HIF-1alpha". Oncology Reports. 16 (4): 929–935. doi:10.3892/or.16.4.929. PMID 16969516.
  62. ^ Zhu X, Zhang X, Wang H, Song Q, Zhang G, Yang L, et al. (July 2012). "MTA1 gene silencing inhibits invasion and alters the microRNA expression profile of human lung cancer cells". Oncology Reports. 28 (1): 218–224. doi:10.3892/or.2012.1770. PMID 22576802.
  63. ^ Li Y, Chao Y, Fang Y, Wang J, Wang M, Zhang H, et al. (May 2013). "MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b". Journal of Experimental & Clinical Cancer Research. 32 (1): 33. doi:10.1186/1756-9966-32-33. PMC 3671210. PMID 23718732.
  64. ^ Aramaki Y, Ogawa K, Toh Y, Ito T, Akimitsu N, Hamamoto H, et al. (July 2005). "Direct interaction between metastasis-associated protein 1 and endophilin 3". FEBS Letters. 579 (17): 3731–3736. doi:10.1016/j.febslet.2005.05.069. PMID 15978591. S2CID 2422645.
[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

Retrieved from "https://en.wikipedia.org/w/index.php?title=MTA1&oldid=1245924108"